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Abstract 
Background: Non‑peptidergic nociceptive neurons are a sub‑population of small diameter primary sensory neu‑
rons that comprise approximately 50 % of the C fiber population. Together with the peptidergic sub‑population, they 
transmit nociceptive information from the periphery to the superficial dorsal horn of the spinal cord. Despite the 
numerous studies investigating the role of the non‑peptidergic primary afferents, their role in normal nociception 
and in pain remains poorly understood. Our lab has previously demonstrated that, in rat models of neuropathic and 
inflammatory pain, there is a de novo expression of substance P receptors (NK‑1r) by lamina I pyramidal projection 
neurons, a neuronal population that normally does not express these receptors.
Results: In this study, we used a ribosomal toxin, saporin, conjugated to the lectin IB4 to selectively ablate the non‑
peptidergic nociceptive C fibers, to investigate if the loss of these fibers was enough to induce a change in NK‑1r 
expression by lamina I projection neurons. IB4‑saporin treatment led to the permanent ablation of the IB4‑positive 
afferents but also to a small non‑significant reduction in CGRP‑positive afferents. An overall increase in immunoreac‑
tivity for the NK‑1r was observed in lamina I projection neurons, however, the lack of non‑peptidergic afferents did not 
increase the number of lamina I pyramidal projection neurons immunoreactive for the receptor.
Conclusions: Our results demonstrate that the deletion of the non‑peptidergic afferents, at the L4–L5 spinal levels, is 
not sufficient to trigger the de novo expression of NK‑1r by projection pyramidal neurons but increases the expression 
of NK‑1r in fusiform and multipolar projection neurons. Furthermore, our data suggest that a neuropathic component 
is essential to trigger the expression of NK‑1r by pyramidal neurons.
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Background
Most of the pain-related (nociceptive) information is 
relayed from the periphery to the spinal dorsal horn via 
small diameter primary afferents, which represent either 
unmyelinated (C) or thinly myelinated (Aδ) axons, with 
only a minority being of larger diameter (for reviews see 
[1, 2]). Usually, the smaller diameter nociceptive afferents 
are classified into two mostly independent subpopulations, 
the peptidergic and non-peptidergic [3, 4]. The peptidergic 
fibers express substance P (SP) and calcitonin gene-related 
peptide (CGRP) and depend on nerve growth factor for 
survival postnatally, while the non-peptidergic fibers are 
devoid of neuropeptides, bind the Griffonia simplicifolia 
isolectin-B4 (IB4), express the purinergic receptor P2X3 
and depend on glial-derived neurotrophic factor for post-
natal survival [5–7]. These populations also differ in their 
central termination in the spinal cord. Indeed, the peptider-
gic afferents terminate mostly in lamina I and outer lamina 
II, while the non-peptidergic project mostly to inner lamina 
II [1, 8–10]. A considerable number of peptidergic affer-
ents, as well as a few non-peptidergic afferents terminate in 
contact with lamina I projection neurons [11, 12].
Lamina I projection neurons comprise three popula-
tions; fusiform, multipolar and pyramidal, which have 
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distinctive morphology [13–16] and, possibly, function 
[17]. Fusiform neurons have an elongated soma with 
two dendrites at each end. Physiologically, in the cat, 
they have been shown to be nociceptive specific (NS), 
and respond to noxious heat and pinch [17]. Multipo-
lar neurons have four or more dendrites arising from 
an irregularly-shaped soma and have been shown to be 
either NS or HPC (polymodal neurons responding to a 
variety of stimuli, including noxious heat, pinch and nox-
ious and innocuous cold) [17]. In horizontal sections, 
pyramidal neurons have a triangular-shaped soma with 
one dendrite at each of the three tips. These neurons do 
not respond to noxious stimuli, however, they respond 
to innocuous cooling (COOL cells) [17]. While fusiform 
and multipolar neurons express the SP receptor (NK-1r) 
in rat and primate, most pyramidal neurons do not [13, 
14]. This difference in NK-1r expression might provide a 
basis for why fusiform and multipolar neurons are noci-
ceptive, whereas most pyramidal neurons might be non-
nociceptive under physiological conditions [13, 14, 18].
The correlation between morphology and function of 
lamina I projection neurons is not accepted by all inves-
tigators. In rat, a majority of spinoparabrachial neurons 
were shown to respond to noxious stimuli [19, 20], and 
a high percentage of lamina I pyramidal projection neu-
rons were considered NK-1r immunoreactive by another 
group [11, 21, 22]. However, our laboratory has con-
sistently found that in naïve rats only about 22 % of the 
pyramidal neurons express the NK-1r [8, 23]. Interest-
ingly, we found that the percentage of pyramidal neu-
rons expressing the NK-1r increased drastically in animal 
models of neuropathic and arthritis pain [23, 24]. Fur-
thermore, there was a significant increase in SP-immu-
noreactive innervation onto these neurons [23, 24]. These 
results indicate a phenotypic switch in pyramidal projec-
tion neurons in models of pain. What precipitates this 
phenomenon remains unknown.
In a chronic constriction injury model, a long-term loss 
of non-peptidergic afferents was reported both peripher-
ally [25] and centrally [26, 27]. Because we have recently 
shown that lamina I projection neurons receive inner-
vation from non-peptidergic afferents [12], it is possi-
ble that it is simply the loss of these fibers that triggers 
the upregulation of NK-1r on pyramidal neurons after 
nerve injury. To investigate this possibility, we used IB4 
conjugated to the ribosomal toxin saporin, which when 
injected into the sciatic nerve leads to a permanent abla-
tion of the non-peptidergic C fibers, mostly sparing the 
other fibers populations [28, 29]. Our main objective was 
to investigate whether the cytotoxic ablation of IB4-bind-
ing afferents was sufficient to induce a de novo expres-
sion of NK-1r by pyramidal neurons in otherwise naive 
rats or whether the increase in NK-1r observed in those 
animals was a result of increased immunoreactivity in the 
neurons that normally express it. Our working hypoth-
esis was that a de novo expression of NK-1 receptors by 
lamina I pyramidal neurons should be partially triggered 
by the loss of the non-peptidergic C-fiber population. 
Ideally, we would have liked to suppress the peptidergic 
afferents as well, but there is not yet any specific way of 
ablating this population in rats. Our results suggest that 
the loss of non-peptidergic afferents does not play a sig-
nificant role in the phenotypic switch of lamina I pyram-
idal neurons that we observed previously in a model of 
neuropathic pain [23].
Results
Behavioral assessment following injection of IB4‑saporin
Animals injected with IB4-saporin into the sciatic nerve 
did not display any changes in evoked thresholds to the 
application of von Frey hairs (Fig. 1a), to an acute noxious 
stimulus (pin prick) (Fig. 1b) or to noxious thermal stim-
uli (Fig. 1c) up to 21 days following IB4-saporin injection 
when compared to vehicle-injected sham animals.
There was no difference from baseline in the con-
tralateral side, either in IB4-saporin-injected or vehicle-
injected groups (Fig. 1).
Changes in spinal dorsal horn following IB4‑saporin 
injection
At 3  weeks after the injection of IB4-saporin into the 
sciatic nerve, we detected a virtually complete loss of 
non-peptidergic afferents on the side ipsilateral to the 
injection at the level of the L4–L5 spinal segments com-
pared to shams which had no loss (Fig. 2). The area of loss 
of staining corresponded to the medial two-thirds of the 
dorsal horn. The labeling persisting in the lateral third 
corresponded to non-sciatic afferents. Quantitative anal-
ysis of IB4-positive varicosities (lamina II), 21 days after 
injection in the sciatic nerve, supported this observation 
(Fig.  3a). The density of IB4-positive varicosities ipsilat-
eral to IB4-SAP injection decreased significantly com-
pared to sham animals (Fig. 3a). We also detected a small 
(Fig.  2) but non-significant loss of CGRP-immunoreac-
tive (ir) varicosities in laminae I–II in IB4-SAP injected 
rats (Fig. 3b) compared to sham animals. There were no 
contralateral changes in either IB4 or CGRP labeling 
(Fig. 3).
Interestingly, we observed an increase in NK-1r immu-
noreactivity in lamina I in IB4-saporin-treated rats when 
compared to sham animals (Fig. 4).
Observations in lamina I spinoparabrachial neurons
As in previous publications from our laboratory, spinopa-
rabrachial lamina I neuronal populations were identi-
fied based on the dendritic arborization and cell body 
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shape as viewed in the horizontal plane. Multipolar 
neurons possess four or more primary dendrites aris-
ing from an irregularly-shaped cell body (Fig.  5a). Fusi-
form neurons have one dendrite arising from each end 
of an elongated soma (Fig. 5b). Pyramidal neurons have a 
triangularly-shaped soma with a primary dendrite origi-
nating from each of the three corners (Fig. 5c). Some cells 
displayed features transitional between two of the cell 
types described above or had a portion of the cell body 
and/or proximal dendritic tree truncated due to section-
ing. These latter neurons were not classifiable and were 
considered as “unclassified”.
In sham animals, we confirmed our previous obser-
vations that spinoparabrachial multipolar and fusi-
form neurons displayed immunoreactivity for NK-1r 
in a high proportion of cells, whereas pyramidal neu-
rons were almost never immunoreactive for the recep-
tor (Figs. 5, 6). We observed an increase in the intensity 
of NK-1r staining in multipolar and fusiform neurons, 
when comparing the ipsilateral side of the spinal dorsal 
horn of IB4-saporin-injected animals (Fig.  5d, e) to the 
ipsilateral side of vehicle-injected sham animals (Fig. 5a, 
b), although there was no change in the proportion of 
neurons expressing immunoreactivity for the receptor 
(Fig.  6). Surprisingly, the number of pyramidal neurons 
expressing detectable NK-1r immunoreactivity remained 
very low (Fig. 6).
Discussion
In this study, we observed that the selective ablation of 
non-peptidergic nociceptive primary afferents by means 
of IB4-saporin injection into the sciatic nerve did not 
cause any change in pain-related behavior compared 
to sham animals. This raises the possibility that normal 
behavioral function was maintained either due to redun-
dancy in the IB4 afferent population or due to a com-
pensatory mechanism in the spinal cord. We detected an 
overall increase in the expression of NK-1r in populations 
of lamina I projection neurons that already expressed the 
NK-1r, which would support the idea of spinal compen-
satory mechanisms. Nevertheless, we did not observe any 
de novo expression of NK-1r by pyramidal neurons or 
any change in the total number of lamina I neurons that 
expressed the NK-1r, in agreement with the absence of 
behavior changes.
Effect of IB4‑saporin injection on non‑peptidergic primary 
sensory neurons
When injected in a peripheral nerve, IB4-saporin is 
known to cause a selective loss of primary afferents bind-
ing IB4 [28, 29]. The lectin IB4 from the conjugate binds 
selectively to the α-d-galactoside of versican, an extracel-
lular matrix protein expressed only on the non-peptider-
gic afferents and a small number of peptidergic afferents. 
IB4-saporin is retrogradely transported to the dorsal root 
ganglia, where the saporin component induces cell death 
through mitochondrial toxicity. Several studies agree that 




Fig. 1 Behavioral characterization at several time points follow‑
ing IB4‑saporin injection. a Assessment of mechanical allodynia 
using von Frey filaments in IB4‑saporin‑treated and sham animals; 
mechanical thresholds were not significantly different from the sham 
group. b Assessment of mechanical hyperalgesia using pin prick in 
IB4‑saporin‑injected and sham groups; there was no significant differ‑
ence in mechanical nociceptive rating between IB4‑saporin‑injected 
and sham groups. c Assessment of thermal hyperalgesia using the 
Hargreaves test in IB4‑saporin‑injected and sham groups; IB4‑saporin‑
injected animals did not display a significant difference in withdrawal 
latencies at any of the time points studied following IB4‑saporin injec‑
tion when compared with the sham group. N = 6, two‑way ANOVA 
with Bonferroni post hoc
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IB4-saporin injection and that this loss persists indefi-
nitely as it results from cell death [28, 29]. In addition to a 
decrease in number of IB4-positive varicosities in lamina 
II, we observed a small, non-significant decrease in the 
density of CGRP-ir peptidergic varicosities in laminae I–
II. This result might be correlated with studies that high-
lighted the binding of IB4 on peptidergic afferents [7, 30]. 
This result is in agreement with the slight decrease in SP 
or CGRP immunoreactivity following IB4-saporin treat-
ment reported by previous studies [28, 29, 31].
Behavioral changes following IB4‑saporin injection
Consistent with previous studies [28, 29], we did not 
detect any changes in the pain thresholds for innocu-
ous mechanical or noxious mechanical and thermal 
stimuli 21  days after IB4-saporin injection. A previous 
study from our laboratory in which the IB4-saporin was 
injected bilaterally into the mental nerves did not reveal 
any difference from controls when mechanical thresholds 
were tested in the lower lip skin [31]. These results are in 
agreement with previous work that describes the lack of 
behavioral changes following ablation of IB4-positive epi-
dermal innervations [32]. On the other hand, our results 
at earlier time points differ from those of groups [28, 29] 
who previously injected IB4-saporin into the sciatic nerve 
of rats and reported a transient elevation in mechanical 
and thermal thresholds at early time points (up to day 14 
after IB4-saporin injection).
This lack of mechanical and thermal changes follow-
ing the complete ablation of non-peptidergic afferents 
after an intrasciatic IB4-saporin injection, may indicate 
a redundancy in the unmyelinated C fiber populations. 
In the rat, the peptidergic and non-peptidergic afferents 
both express the vanilloid receptor TRPV1 [33], which 
suggests that these two C fiber populations overlap in 
nociceptive function, unlike studies in the mouse, which 
advocate specific modalities for each of the two C fiber 
populations [34, 35]. Therefore, it is possible that even 
if they are slightly affected, the peptidergic afferents are 
able to compensate for the loss of the non-peptidergic 
afferents.
Changes in dorsal horn lamina I projection neurons 
following IB4‑saporin injection
Following the loss of non-peptidergic afferents after the 
intrasciatic injection of IB4-saporin, we observed an 
overall increase in NK-1r immunoreactivity by dorsal 
horn lamina I projection neurons (Fig. 4). Previous stud-
ies demonstrated an increased NK-1r immunoreactivity 
associated with a novel expression of the receptor by lam-
ina I pyramidal neurons in pain models of inflammation 
[24] and neuropathy [23]. This increase suggested a com-
pensatory mechanism at the level of the spinal cord, how-
ever, our quantitative study of NK-1r expression by the 
three lamina I projection neuronal populations did not 
reveal any novel expression of NK-1r by pyramidal neu-
rons or an increased number of cells of the fusiform or 
multipolar neuronal populations (Fig.  6). This indicated 
that the increased NK-1r immunoreactivity we detected 
was caused by an increase in the number of receptors 
Fig. 2 Confocal low magnification images from transverse sections comparing the ipsilateral side of the dorsal horn of vehicle‑injected animals 
(a–c) with the ipsilateral side of IB4‑saporin‑injected (d–f) rats, at 21 days post‑injection. In the lower panels, note the virtually complete depletion 
of IB4 staining (in red), except in the lateral third of the dorsal horn, that does not receive sciatic afferents. It is important to note that although 
IB4‑saporin binds to non‑peptidergic fibers, a slight reduction of CGRP immunoreactivity (in green) in the area of the lesion was noticeable when 
compared to sham. Scale bar 100 µm
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by cell populations already expressing it. These results 
were expected since the de novo expression of NK-1r by 
pyramidal neurons seems to correlate with a chronic pain 
state, whereby the nociceptive system is being stimulated 
following an injury, which was not the case in this study.
Work by Taylor et al. [31] in a model of trigeminal neu-
ropathic pain demonstrated an increased hypersensitivity to 
mechanical stimuli when the neuropathic injury is preceded 
by an IB4-saporin injection, however these results should be 
confirmed in a sciatic nerve neuropathic pain model.
Conclusions
In this study, we have demonstrated that the lesioning of 
the non-peptidergic afferents of the sciatic nerve does 
not cause any significant pain-related behavior change 
for up to 21 days after lesion. In the spinal dorsal horn, 
changes were limited to the loss of the non-peptidergic 
afferents and a strong increase in overall immunoreactiv-
ity for the NK-1r, without a change in the overall number 
of projection neurons expressing the NK-1r. These results 
suggest that, in naïve rats, the IB4-saporin-induced loss 
of non-peptidergic afferents is not sufficient to trigger the 
NK-1r de novo expression by pyramidal neurons.
Methods
The experimental procedures followed the guidelines for 
the Care and Use of Experimental Animals of the Cana-
dian Council on Animal Care and the International Asso-
ciation for the Study of Pain (IASP). All protocols were 
approved by the McGill University Faculty of Medicine 
Animal Care Committee.
Forty male Sprague–Dawley rats (Charles River, QC, 
Canada), weighing between 220 and 230  g, were used. 
The number of animals used and their suffering was kept 
to the minimum necessary for the conduction of the 
study. Animals were exposed to 12  h light/dark cycles 
with food and water available ad libitum and were housed 
four animals to a cage fitted with soft bedding and a plas-
tic tube for an enriched environment.
Animal preparation
Surgeries
Animals were anesthetized with 5 % isoflurane in oxygen. 
Unilateral injections were carried out on the left sciatic 
nerve. Using blunt dissection, the left biceps femoris 
and gluteus superficialis muscles were separated. Care 
was taken to minimize the stretching of the sciatic nerve 
when it was separated from the surrounding connective 
tissue. Experimental animals received a total of 6 µL of an 
800 μg/mL solution of IB4-saporin (Advanced Targeting 
Systems, San Diego CA, USA) in 0.2 M Phosphate Buff-
ered Saline (PBS) and Fast Green Dye (Sigma, MO, USA) 
injected at three injection sites into the sciatic nerve 
proximal to its branching point using calibrated glass 
micropipettes (Wiretrol II, Drummond Scientific Com-
pany, Broomall, PA, USA). The Fast Green dye was used 
to monitor the accuracy of the injection. The control 
group was injected with vehicle solution of 6  µL 0.2  M 
PBS in Fast Green dye using the same method. The inci-
sion was sutured in two layers using 4-0 Vicryl sutures 
(Ethicon Inc, New Jersey, USA). Animals were returned 
to their cages to recover. No difference in weight gain 
between experimental and sham groups was observed at 
any time point throughout the study.
Injection of tracer
To retrogradely trace projection neurons, animals were 
first anesthetized using 5 % isoflurane in oxygen, placed 
in a stereotaxic apparatus (David Kopf Instruments, 
a
b
Fig. 3 Quantitative analysis of the density of IB4‑binding (a) and 
CGRP‑ir (b) varicosities per area unit (µm2) in the sciatic territory, 
21 days after injection in the sciatic nerve of IB4‑saporin (IB4‑SAP, 
N = 5) or saline (sham, N = 4), in the ipsilateral dorsal horn. a Ipsilat‑
eral to IB4‑saporin injection the number of IB4‑positive varicosities 
was reduced (IB4‑SAP) compared to sham animals (Student’s t‑test; 
*P < 0.02). b Ipsilateral to IB4‑saporin injection, the density of CGRP ir 
varicosities was slightly reduced, but the difference from sham was 
not significant (Student’s t‑test)
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Tujunga, CA, USA) and the head stabilized with non-
perforating ear bars. The coordinates for the parabra-
chial nucleus (rostral/caudal: −9.12  mm; medial/lateral: 
−2.1 mm; dorsal/ventral: −6.3 mm) were calculated, with 
Bregma as the reference point, from the Paxinos & Wat-
son Rat Brain Atlas [36]. A small hole was drilled through 
the skull at the target point, exposing the dura mater. A 
glass micropipette (Wiretrol II, Drummond Scientific 
Company, Broomall, PA, USA) was lowered, through the 
dura mater, to the stereotaxic position of the parabra-
chial nucleus and 2 µL of 1.0 % solution of cholera toxin 
subunit B (CTb) (List, Campbell, CA, USA) was slowly 
injected over a period of 20 min. To minimize leakage of 
the tracer, a 10  min waiting period was imposed before 
the micropipette was retracted from its position. CTb 
was injected 7 days prior to sacrificing the animals.
Behavior testing
Animals were always habituated to the testing apparatus 
for 30 min prior to testing. Baseline behavioral thresholds 
were measured for 2 consecutive days prior to surgical 
treatments.
Testing for mechanical allodynia
Animals were placed in clear plastic enclosures elevated 
on a mesh grid, which allowed complete access to the 
ventral side of the animal. Animals were tested using 
the up-down method previously described by Chaplan 
et al. [37]. Filaments of increasing stiffness were applied 
to the mid-plantar area of the hind paw, avoiding the 
foot pads, until an obvious withdrawal or flicking/lick-
ing behavior occurred. In case of a positive response, 
the next weaker filament was presented, however, in 
the case of a negative response; the next stronger fila-
ment was applied. This process was repeated until six 
responses were recorded and a mean threshold was cal-
culated. The testing was performed on the right paw of 
all the rats followed by the testing of the left paw in the 
same manner.
Testing for mechanical hyperalgesia
Mechanical hyperalgesia was assessed using the pin 
prick method described by Coderre et al. [38]. The point 
of a blunted 23 gauge needle was applied to the skin of 
the heel (touching, but not penetrating). Behavioral 
responses to the pin prick were rated according to the 
following scale: 0  =  no response; 1  =  rapid paw flick-
ing, stamping, or shaking (less than 1  s); 2  =  repeated 
paw stamping, shaking, or paw lift less than 3  s; 
3 =  above behaviors or hind paw licking for more than 
3 s; 4 = above behaviors for more than 3 s and hind paw 
licking for more than 3 s. An additional point was added 
if any vocalizations occurred. The mean for reaction for 
each paw was calculated.
Testing for thermal hyperalgesia
The Hargreaves test [39] was used to measure thermal 
nociceptive thresholds. Clear plastic enclosures were 
set on top of a glass floor. The light source was directed 
onto skin area of the paw in contact with the glass. The 
Fig. 4 Confocal images comparing NK‑1r immunoreactivity in the ipsilateral side of vehicle‑injected (a–c) and IB4‑saporin‑injected (d–f) animals, in 
transverse sections, 21 days after injection. NK‑1 receptors—NK‑1 (in green), non‑peptidergic afferents—IB4 (in red). The framed regions in a and d 
are enlarged in b, c, e and f. Scale bars 100 µm
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time from turning on of light source until withdrawal was 
noted. Testing included three trials per paw with each 
trial being completed for all the animals before the start 
of the next trial. This ensured there was a 30  min wait 
before the start of the next trial to minimize desensitiza-
tion effects. The average of the three trials per paw was 
calculated.
Animal perfusion
At the end of the experiment (21 days after the injection 
IB4-saporin or sham injection), the animals were deeply 
anesthetized with Equithesin (6.5 mg chloral hydrate and 
3  mg sodium pentobarbital in a volume of 0.3  mL, i.p., 
per 100 g body weight). They were then perfused through 
the left cardiac ventricle with perfusion buffer (for com-
position see [40]) for 1  min, followed by 30  min of 4  % 
paraformaldehyde in 0.1  M phosphate buffer (PB), pH 
7.4. The brain and spinal cord segments L4–L5 were 
extracted and postfixed for 4 and 2 h, respectively, in 4 % 
paraformaldehyde in PB. The specimens were then cryo-
protected in 30 % sucrose in PB overnight at 4 °C.
Immunohistochemistry
Serial 100  µm-thick coronal sections of the brain were 
obtained, to examine the site of injection at the level of 
the parabrachial nucleus. L4–L5 spinal cord segments 
were trimmed and cut serially at 50 µm thickness. Both 
horizontal and coronal sections were cut using a freezing-
sledge microtome (Leica, Richmond Hill, ON, Canada). 
Sections were collected as free-floating in phosphate-
buffered saline (PBS) with 0.2 % Triton-X 100 (PBS + T).
To examine lamina I projection neurons, horizontal sec-
tions were incubated in 10 % normal donkey serum (Jack-
son, West Grove, PA, USA) in PBS + T for 1 h at room 
temperature to block unspecific staining. Subsequently, 
spinal cord sections were incubated, for 48 h at 4 °C, with 
the primary antibodies: goat anti-CTb at 1:5000 dilution 
(List Biological), rabbit anti-NK-1r, raised against residues 
376–407 of the C-terminal sequence of the rat receptor, 
Fig. 5 Confocal images at high magnification showing the morphol‑
ogy and NK‑1r expression by the lamina I spinoparabrachial neuronal 
population in IB4‑saporin‑injected animals compared to the vehicle‑
injected sham group at the 21 days time point. Both fusiform and 
multipolar neurons showed an increase in NK‑1r immunoreactivity 
in each cell (d, e), compared to the sham group (a, b). However, the 
great majority of pyramidal neurons did not display NK‑1r immuno‑
reactivity following IB4‑saporin injection at the same time point (c, f). 
NK‑1 receptor—NK‑1 (in green), retrograde tracer CTb (in red). Scale 
bar 20 µm
◂
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at 1:10,000 dilution (Sigma) and IB4 conjugated to Alex-
aFluor 647 (Molecular Probes) in PBS + T containing 5 % 
normal donkey serum. Then, the sections were washed 
several times with PBS + T and incubated for 2 h at room 
temperature with secondary antibodies preabsorbed 
with 10  mg/mL acetone rat brain powder: donkey anti-
goat Rhodamine Red X (1:200, Jackson, West Grove, PA, 
USA) and donkey anti-rabbit AlexaFluor 488 (Molecular 
Probes). Finally, sections were washed with PBS, mounted 
on gelatin-subbed slides and coverslipped with an anti-
fading mounting medium (Aqua Polymount; Polysciences, 
Warrington, PA, USA). Slides were stored at −4 °C. Con-
trol sections were processed by omitting the primary anti-
body which resulted in complete loss of immunoreactivity. 
The above protocol was also followed for the comparison 
of NK-1 receptor immunoreactivity in sham- and IB4-
saporin-treated groups in transverse sections and the labe-
ling of non-peptidergic afferents in horizontal sections, 
however in these two cases IB4 was conjugated to Alex-
aFluor 568 (Molecular Probes) instead of AlexaFluor 647.
To examine the primary afferent populations in the 
spinal dorsal horn, sections were processed as described 
above except that they were incubated for 48 h with IB4 
conjugated to AlexaFluor 568, at 1:200 dilution (Molec-
ular Probes) and rabbit anti-CGRP, at 1:2000 dilution 
(Sigma) followed by incubation with goat anti-rabbit 
AlexaFluor 488 (Molecular Probes).
Brainstem sections of the injection site were incubated 
with anti-CTb antibody (List Biological) followed by 
biotinylated donkey anti-goat IgG (Jackson, West Grove, 
PA, USA) and streptavidin conjugated to AlexaFluor 568 
(Molecular Probes). All sections were mounted and cov-
erslipped as described above.
Antibody specificity
As controls for immunocytochemistry, some sections 
were processed by omitting the primary antibodies or 
by pre-absorption with the peptide used to generate the 
antibody, in both cases resulting in a complete loss of 
immunoreactivity.
The goat anti-CTb antibody (List Biological; 703, lot 
7032A5) was raised against purified CTb and its speci-
ficity was demonstrated by the lack of any staining in 
animals not injected with CTb. The rabbit anti-NK-1r 
antibody (Sigma; S8305, lot 084K4845) was generated 
against a synthetic peptide corresponding to amino 
acids 393–407 of the C-terminus region of the rat 
NK-1r conjugated to KLH as the immunogen and puri-
fied by ion-exchange chromatography. In Western blots 
from rat brain, the antibody was found to label only a 
specific band at 46  kDa, whose staining is specifically 
inhibited by incubation with the blocking peptide (data 
supplied by the manufacturer). Furthermore, it was 
shown that it does not produce any staining in NK-1r 
knockout mice, although it recognizes the receptor in 
wild type mice [41]. The rabbit anti-CGRP antibody 
(Sigma; C8198, lot 070M4835) was generated against 
synthetic rat CGRP conjugated to KLH as the immu-
nogen. Using dot-blot immunoassay, the antibody was 
found to recognize rat CGRP conjugated to bovine 
serum albumin (BSA); it only shows cross-reactivity 
with CGRP (human) and β-CGRP (human) (data sup-
plied by the manufacturer). Specific staining was abol-
ished by pre-incubating the antiserum with rat CGRP. 
This antibody was previously used by us as a marker for 
peptidergic fibers in rat skin, dorsal root ganglia and 
spinal cord [25, 42–44].
Fig. 6 Quantitative comparison of the lamina I neuronal populations immunoreactive for the NK‑1r (NK‑1 only), retrogradely labeled from the 
parabrachial nucleus (CTb only) or double labeled (NK‑1 + CTb), on the ipsilateral side of IB4‑saporin‑injected or sham group at 21 days. There 
were no changes in the number of fusiform, multipolar, or pyramidal neurons immunoreactive for one or both of the markers when comparing 
IB4‑saporin‑injected to sham group. Only cells with visible nuclei were counted. Values represent average number of neurons (±SEM) counted per 
animal. N = 6, one‑way ANOVA
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Morphological characterization and quantification 
of lamina I neurons
Our criteria of identification and quantification of lamina 
I neurons have been described extensively in previous 
publications from our laboratory (see e.g. [24]). In brief, 
in the current study, six serial, 50  µm-thick horizontal 
sections were cut from the dorsal part of the L4–L5 spi-
nal segments. Six rats were used per group. Sections were 
examined under a PlanFluotar 40× oil immersion objec-
tive on a Zeiss Axioplan 2e imaging fluorescence micro-
scope. Only neurons with visible nuclei, ipsilateral to the 
injection side, and with the cell body entirely located 
within the plane of the section, as assessed with the fine 
focus of the microscope, were included in our quantifi-
cations. Lamina I neurons were classified according to 
the shape of their cell body and their dendritic arboriza-
tion in the horizontal plane. Fusiform neurons have two 
primary dendrites with one arising from each end of an 
elongated, spindle-shaped soma. Multipolar neurons 
have an irregularly-shaped cell body with four or more 
primary dendrites arising from the cell body. Pyrami-
dal neurons have a triangularly-shaped soma with three 
primary dendrites arising from each of the cell body’s 
corners, in some cases, a fourth primary dendrite, ori-
ented toward the white matter, was visible by confocal 
reconstruction or by adjusting the fine focus of a conven-
tional fluorescence microscope. Neurons were classified 
as “unclassified” if they exhibited features transitional 
between any of these types, as they did not meet the 
required criteria.
To obtain images for the illustrations and to confirm 
the data obtained with conventional fluorescence micros-
copy, some sections were examined using a Zeiss LSM 
510 confocal scanning laser microscope, using a multi-
track scanning method and appropriate filters for the 
separate detections of AlexaFluor 488, AlexaFluor 568 
or Rhodamine Red X and AlexaFluor 647. Low magnifi-
cation images represent single optical section, whereas 
images of individual neurons represent serial optical sec-
tions obtained along the z-axis (z-stacks), using a 63× 
plan-apochromatic oil-immersion objective.
Quantitative analysis of CGRP immunolabeling 
and IB4‑binding
Four sham animals and 5 IB4-SAP animals were used for 
the quantitative analysis. For quantification IB4-positive 
and CGRP-ir varicosities, single-plane confocal images 
were obtained in the confocal microscope using the 63× 
objective, equidistantly from the lateral and medial lim-
its of the dorsal horn. This region corresponded to an 
area of maximum depletion of IB4 binding ipsilateral to 
the IB4-SAP injection. The images, originally in the Zeiss 
file format, were exported to TIFF and quantified using 
the ImageJ software. For each animal, 8–11 spinal cord 
cross sections were used, and two images (one from the 
ipsi- and the other from contralateral side) were obtained 
per section. In each image, a rectangle of 125 × 110 µm 
and 125 ×  100  µm for IB4 and CGRP labeling, respec-
tively, was placed with longer axis centered on the mid-
dle third of lamina II (for IB4) or with the dorsal longer 
side of the rectangle at on the white matter-lamina I bor-
der (for CGRP). To compensate overlapping or clustered 
varicosities, a correction was performed by the ImageJ 
software. The average number of varicosities per sec-
tion’s side (ipsilateral or contralateral), per µm2, for each 
animal was calculated in the two conditions (Sham or 
IB4-SAP) ± SEM.
Statistics
Two-way ANOVA followed by Bonferroni correction 
were applied to compare differences in pain-related 
behavior at each time point between the sham and exper-
imental groups. One-way analyses of variance (ANOVA) 
was applied to compare the differences between sham 
and experimental groups within each neuronal popula-
tion at the 21 day time point post-IB4-saporin injection. 
To compare differences in densities of IB4 or CGRP-
labeled varicosities, t-tests were used. Values were 
expressed as mean  ±  SEM. The significance level was 
set at P  <  0.05. All data were analyzed using GraphPad 
Prism 5 for Windows (GraphPad Software, San Diego, 
CA, USA).
Figure preparation
All immunofluorescence images were obtained with the 
confocal microscope. They were saved in the Zeiss LSM 
format, exported as TIFF files and prepared for publica-
tion using Adobe Photoshop 7.0 (San Jose, CA, USA). 
The original images were optimized for brightness and 
contrast, and pseudo colors were assigned to the mark-
ers (green to NK-1r and CGRP and red to IB4 and CtB), 
to ensure uniformity throughout the paper, but no other 
image manipulation was done.
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